J&J | Frais De Vente Et D'Administration



Selling And Administration Expenses Changement Date
AbbVie USD 3.25B 40M 2025-06
Abbott USD 3.09B 39M 2025-06
Amgen USD 1.69B 4M 2025-06
AstraZeneca USD 5.01B 1.42B 2025-06
Baxter International USD 718M 15M 2025-06
Bayer EUR 3.55B 162M 2025-06
Becton, Dickinson and Co. USD 1.32B 47M 2025-06
Biogen USD 583.8M 11.3M 2025-06
Boston Scientific USD 1.72B 119M 2025-06
Bristol-Myers Squibb USD 1.71B 129M 2025-06
CONMED USD 136.02M 6.98M 2025-06
Cooper Companies USD 399M 11.1M 2025-04
Dexcom USD 328M 17.9M 2025-06
Edwards Lifesciences USD 502M 36.3M 2025-06
Eli Lilly USD 2.75B 390.8M 2025-06
Gilead Sciences USD 1.36B 100M 2025-06
GlaxoSmithKline GBP 2.14B 80M 2025-06
Globus Medical USD 303.62M 60.82M 2025-06
Hologic USD 251.3M 15.1M 2025-06
Insulet USD 253.3M 7.3M 2025-06
Integra LifeSciences USD 179.89M 15.88M 2025-06
Intuitive Surgical USD 561.2M 2.2M 2025-06
J&J USD 5.89B 777M 2025-06
Medtronic USD 2.7B 17M 2025-04
Merck USD 2.63B 104M 2025-06
Merit Medical Systems USD 113.1M 5.61M 2025-06
Novartis USD 3.44B 384M 2025-06
Pfizer USD 3.42B 406M 2025-06
Regeneron Pharmaceuticals USD 634.2M 1.2M 2025-06
Roche Holding CHF 3.61B 381M 2024-12
Sanofi EUR 2.63B 408M 2025-06
Stryker USD 2.08B 221M 2025-06
Tandem Diabetes Care USD 93.05M 11.91M 2025-06
Teva Pharmaceutical Industries USD 959M 40M 2025-06
Vertex Pharmaceuticals USD 424.6M 28.2M 2025-06
Zimmer Biomet Holdings USD 814.8M 56M 2025-06
Zoetis USD 617M 54M 2025-06


J&J Frais De Vente Et D'Administration - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.